Login to Your Account



Essential Acquiring Maret For 2M Shares Of Locked-Up Stock

By Kim Coghill


Monday, March 4, 2002
Essential Therapeutics Inc. on Friday said it will strengthen its clinical and preclinical pipeline through the acquisition of Maret Pharmaceuticals Inc. in a deal valued at up to about $6.8 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription